Preoperative Anti-TNF Therapy is Associated with a Shorter Length of Resected Bowel in Patients Undergoing Ileocolic Resection for Crohn’s Disease

Background Massive or repeated intestinal resections for Crohn’s disease (CD) could lead to disabling consequences. The present study aimed to assess the effect of preoperative anti-TNF therapy on the length of resected bowel and identify risk factors for postoperative morbidity following ileocolic...

Full description

Bibliographic Details
Main Authors: Yuhua Huang, Danhua Yao, Feilong Guo, Zhiyuan Zhou, Yousheng Li
Format: Article
Language:English
Published: Taylor & Francis Group 2022-06-01
Series:Journal of Investigative Surgery
Subjects:
Online Access:http://dx.doi.org/10.1080/08941939.2021.2023713
_version_ 1797684506366312448
author Yuhua Huang
Danhua Yao
Feilong Guo
Zhiyuan Zhou
Yousheng Li
author_facet Yuhua Huang
Danhua Yao
Feilong Guo
Zhiyuan Zhou
Yousheng Li
author_sort Yuhua Huang
collection DOAJ
description Background Massive or repeated intestinal resections for Crohn’s disease (CD) could lead to disabling consequences. The present study aimed to assess the effect of preoperative anti-TNF therapy on the length of resected bowel and identify risk factors for postoperative morbidity following ileocolic resection for CD. Methods Patients undergoing elective ileocolic resection for CD were included prospectively. Medical variables including demographics, Montréal classification, preoperative treatment, surgical details and 30-day postoperative morbidity were collected. Potential impact of preoperative anti-TNF treatment on length of ileocolic specimen and risk factors for postoperative morbidity were investigated. Results One hundred and eight-four patients were included in this study, and 66 (35.9%) of them received anti-TNF agents within 8 weeks prior to surgery. Primary anastomosis was performed in 145 patients (78.8%). The mean length of resected intestine was 10 cm shorter in subjects receiving preoperative anti-TNF treatment than those without preoperative anti-TNF therapy (P < 0.001). The rates of postoperative overall, infectious and intra-abdominal septic morbidity were 29.9%, 19.0% and 7.6%, respectively. In multivariate analysis, anti-TNF therapy < 8 weeks before surgery was independently associated with a shorter length of resected bowel but didn’t increase overall and septic complications, while systemic steroids use within 8 weeks prior to surgery independently increased overall complications and intra-abdominal sepsis. Conclusions Preoperative anti-TNF therapy was associated with a shorter length of resected bowel but not the overall and septic postoperative complications in ileocolic resection for CD. Weaning off systemic steroids before surgery may improve postoperative outcomes in patients with CD.
first_indexed 2024-03-12T00:30:38Z
format Article
id doaj.art-e0248d1281364215b14902eb6e37ec7f
institution Directory Open Access Journal
issn 0894-1939
1521-0553
language English
last_indexed 2024-03-12T00:30:38Z
publishDate 2022-06-01
publisher Taylor & Francis Group
record_format Article
series Journal of Investigative Surgery
spelling doaj.art-e0248d1281364215b14902eb6e37ec7f2023-09-15T10:21:29ZengTaylor & Francis GroupJournal of Investigative Surgery0894-19391521-05532022-06-013561357136510.1080/08941939.2021.20237132023713Preoperative Anti-TNF Therapy is Associated with a Shorter Length of Resected Bowel in Patients Undergoing Ileocolic Resection for Crohn’s DiseaseYuhua Huang0Danhua Yao1Feilong Guo2Zhiyuan Zhou3Yousheng Li4Department of General Surgery, Shanghai Ninth People’s Hospital, Shanghai JiaoTong University School of MedicineDepartment of General Surgery, Shanghai Ninth People’s Hospital, Shanghai JiaoTong University School of MedicineDepartment of General Surgery, Jinling Hospital, School of Medicine, Nanjing UniversityDepartment of General Surgery, Shanghai Ninth People’s Hospital, Shanghai JiaoTong University School of MedicineDepartment of General Surgery, Shanghai Ninth People’s Hospital, Shanghai JiaoTong University School of MedicineBackground Massive or repeated intestinal resections for Crohn’s disease (CD) could lead to disabling consequences. The present study aimed to assess the effect of preoperative anti-TNF therapy on the length of resected bowel and identify risk factors for postoperative morbidity following ileocolic resection for CD. Methods Patients undergoing elective ileocolic resection for CD were included prospectively. Medical variables including demographics, Montréal classification, preoperative treatment, surgical details and 30-day postoperative morbidity were collected. Potential impact of preoperative anti-TNF treatment on length of ileocolic specimen and risk factors for postoperative morbidity were investigated. Results One hundred and eight-four patients were included in this study, and 66 (35.9%) of them received anti-TNF agents within 8 weeks prior to surgery. Primary anastomosis was performed in 145 patients (78.8%). The mean length of resected intestine was 10 cm shorter in subjects receiving preoperative anti-TNF treatment than those without preoperative anti-TNF therapy (P < 0.001). The rates of postoperative overall, infectious and intra-abdominal septic morbidity were 29.9%, 19.0% and 7.6%, respectively. In multivariate analysis, anti-TNF therapy < 8 weeks before surgery was independently associated with a shorter length of resected bowel but didn’t increase overall and septic complications, while systemic steroids use within 8 weeks prior to surgery independently increased overall complications and intra-abdominal sepsis. Conclusions Preoperative anti-TNF therapy was associated with a shorter length of resected bowel but not the overall and septic postoperative complications in ileocolic resection for CD. Weaning off systemic steroids before surgery may improve postoperative outcomes in patients with CD.http://dx.doi.org/10.1080/08941939.2021.2023713crohn’s diseaseileocolic resectionanti-tnfbowel damagepostoperative morbidity
spellingShingle Yuhua Huang
Danhua Yao
Feilong Guo
Zhiyuan Zhou
Yousheng Li
Preoperative Anti-TNF Therapy is Associated with a Shorter Length of Resected Bowel in Patients Undergoing Ileocolic Resection for Crohn’s Disease
Journal of Investigative Surgery
crohn’s disease
ileocolic resection
anti-tnf
bowel damage
postoperative morbidity
title Preoperative Anti-TNF Therapy is Associated with a Shorter Length of Resected Bowel in Patients Undergoing Ileocolic Resection for Crohn’s Disease
title_full Preoperative Anti-TNF Therapy is Associated with a Shorter Length of Resected Bowel in Patients Undergoing Ileocolic Resection for Crohn’s Disease
title_fullStr Preoperative Anti-TNF Therapy is Associated with a Shorter Length of Resected Bowel in Patients Undergoing Ileocolic Resection for Crohn’s Disease
title_full_unstemmed Preoperative Anti-TNF Therapy is Associated with a Shorter Length of Resected Bowel in Patients Undergoing Ileocolic Resection for Crohn’s Disease
title_short Preoperative Anti-TNF Therapy is Associated with a Shorter Length of Resected Bowel in Patients Undergoing Ileocolic Resection for Crohn’s Disease
title_sort preoperative anti tnf therapy is associated with a shorter length of resected bowel in patients undergoing ileocolic resection for crohn s disease
topic crohn’s disease
ileocolic resection
anti-tnf
bowel damage
postoperative morbidity
url http://dx.doi.org/10.1080/08941939.2021.2023713
work_keys_str_mv AT yuhuahuang preoperativeantitnftherapyisassociatedwithashorterlengthofresectedbowelinpatientsundergoingileocolicresectionforcrohnsdisease
AT danhuayao preoperativeantitnftherapyisassociatedwithashorterlengthofresectedbowelinpatientsundergoingileocolicresectionforcrohnsdisease
AT feilongguo preoperativeantitnftherapyisassociatedwithashorterlengthofresectedbowelinpatientsundergoingileocolicresectionforcrohnsdisease
AT zhiyuanzhou preoperativeantitnftherapyisassociatedwithashorterlengthofresectedbowelinpatientsundergoingileocolicresectionforcrohnsdisease
AT youshengli preoperativeantitnftherapyisassociatedwithashorterlengthofresectedbowelinpatientsundergoingileocolicresectionforcrohnsdisease